Detailed price information for Iovance Biotherapeutics Inc (IOVA-Q) from The Globe and Mail including charting and trades.

Introduction: Soft tissue undifferentiated pleomorphic sarcoma (UPS) in extremities is considered a rare neoplasm, corresponding to 5% of soft tissue sarcomas (STS) today. The objective was to ...

In an early-stage clinical trial, half the patients with advanced undifferentiated pleomorphic sarcoma or dedifferentiated liposarcoma responded to the TIL therapy.

Iovance posts narrower Q4 loss as Amtagvi sales jump 33%. Shares soar on 50% ORR data and plans for registrational sarcoma study.

Investing.com -- Iovance Biotherapeutics Inc (NASDAQ:IOVA) shares jumped 32% Tuesday following positive early data from a pilot clinical trial of lifileucel in patients with advanced undifferentiated ...

Iovance shares jump 29% after early cancer trial shows 50% response rate. The company plans FDA talks and a new study in 2026 ...

Iovance Biotherapeutics shares rose after the company shared positive trial results from a treatment designed for soft tissue cancer. The stock gained 26% to $3.65 Tuesday. Shares are still down 32% ...

The company announced encouraging early results from a pilot study evaluating its tumor-infiltrating lymphocyte therapy, ...

Objective Response Rate (ORR) in Advanced Sarcomas Significant Market Opportunity with More than 8,000 Patients Diagnosed Annually in the U.S. and Europe SAN CARLOS, Calif., Feb. 24, 2026 (GLOBE ...

Christopher Lewis Scott, 53, of Mitchell, SD, passed away on January 29, 2026, at Ava’s House Hospice in Sioux Falls. Even during his brave, year-long battle with undifferentiated pleomorphic sarcoma, ...

1 Department of Surgery, Queen Elizabeth Hospital 2, Kota Kinabalu, Sabah. 2 Department of Pathology, Queen Elizabeth Hospital, Kota Kinabalu, Sabah. 3 Department of Surgery, Faculty of Medicine and ...

— Mec-V demonstrates median OS of 21.5 months in patients with treatment-refractory leiomyosarcoma, liposarcoma, and undifferentiated pleomorphic sarcoma compared with approximately 12 months with ...